Evaluation of the Relationship between Diabetes and Smoking and IL-6, IL-17 and IL-23 Levels in Individuals with Stage II, IV Periodontitis

Year 2022, Volume: 23 Issue: 4, 482 - 487, 30.12.2022

Umut Yiğit , Fatih Karaaslan , Ahu Dikilitaş

Abstract

Objective: The purpose of the present investigation was to examine the relationship between diabetes mellitus (DM) and smoking on gingival crevicular fluid (GCF) levels of interleukin (IL)-6, IL-17, and IL-23 in patients with stage II and stage IV periodontitis.
Materials and Methods: Individuals were divided into nine groups according to their periodontal diagnosis, smoking, and DM status: periodontally and systemically healthy individuals (PH-H, n=14), periodontally healthy smokers (PH-S, n=14), periodontally healthy diabetics (PH-D, n=14), systemically healthy individuals with stage II periodontitis (SII-H n=14), smokers with stage II periodontitis (SII-S, n=14), diabetics with stage II periodontitis (SII-D, n=14), systemically healthy individuals with stage IV periodontitis (SIV-H, n=14), smokers with stage IV periodontitis (SIV-S, n=14), and diabetics with stage IV periodontitis (SIV-D, n=14). GCF samples were collected and analyzed.
Results: The mean GCF levels of IL-6, IL-17, and IL-23 in patients with stage IV periodontitis were significantly higher than those in patients with stage II periodontitis and in periodontally healthy individuals.
Conclusion: As the stage of periodontitis increases, the levels of IL-6, IL-17, and IL-23 increase.

Keywords

Diabetes mellitus , gingival crevicular fluid , interleukin , smoking , periodontitis

References

• 1. Eke PI, Borgnakke WS, Genco RJ. Recent epidemiologic trends in periodontitis in the USA. Periodontol 2000 2020; 82: 257-67.
• 2. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol 2018; 89 Suppl 1: S159-72.
• 3. Miranda TS, Heluy SL, Cruz DF, da Silva HDP, Feres M, Figueiredo LC, et al. The ratios of pro-inflammatory to anti-inflammatory cytokines in the serum of chronic periodontitis patients with and without type 2 diabetes and/or smoking habit. Clin Oral Investig 2019; 23: 641-50.
• 4. Miranda TS, Almeida ML, Marins LM, da Silva HDP, Feres M, Duarte PM. Might smoking assuage the pro-inflammatory effect of diabetes in periodontal sites? Oral Dis 2020; 26: 200-12.
• 5. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15: 49-60.
• 6. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103: 1345-52.
• 7. Beadling C, Slifka MK. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp (Warsz) 2006; 54: 15-24.
• 8. Duarte PM, Santos VR, Dos Santos FA, de Lima Pereira SA, Rodrigues DB, Napimoga MH. Role of smoking and type 2 diabetes in the immunobalance of advanced chronic periodontitis. J Periodontol 2011; 82: 429-38.
• 9. Silness J, Löe H. Periodontal Disease in Pregnancy. II. Correlation Between Oral Hygiene and Periodontal Condtion. Acta Odontol Scand 1964; 22: 121-35.
• 10. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 1967; 38: 610-16.
• 11. Persson GR. Periodontal complications with age. Periodontol 2000 2018; 78: 185-94.
• 12. Shiau HJ, Reynolds MA. Sex differences in destructive periodontal disease: a systematic review. J Periodontol 2010; 81: 1379-89.
• 13. Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Periodontol 2000 2020; 82: 214-24.
• 14. Costa FO, Cota LOM. Cumulative smoking exposure and cessation associated with the recurrence of periodontitis in periodontal maintenance therapy: A 6-year follow-up. J Periodontol 2019; 90: 856-65.
• 15. Becerik S, Öztürk VÖ, Atmaca H, Atilla G, Emingil G. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J Periodontol 2012; 83: 1304-13.
• 16. Erdemir EO, Duran I, Haliloglu S. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. J Clin Periodontol 2004; 31: 99-104.
• 17. Cheng WC, Hughes FJ, Taams LS. The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol 2014; 41: 541-9.
• 18. Mitani A, Niedbala W, Fujimura T, Mogi M, Miyamae S, Higuchi N, et al. Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. J Periodontol 2015; 86: 301-9.
• 19. Buduneli N, Buduneli E, Kütükçüler N. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol 2009; 80: 1274-80.
• 20. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004; 75: 37-43.
• 21. Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007; 78: 1545-50.